Free Trial
The Market Does Not Wait. MarketBeat All Access Alerts for $149
Get the Alerts
Claim MarketBeat All Access Sale Promotion
NYSE:CC

Chemours Q3 2026 Earnings Date & Estimates

Chemours logo
$12.82 +0.01 (+0.05%)
Closing price 10/23/2026 03:59 PM Eastern
Extended Trading
$12.83 +0.01 (+0.11%)
As of 07:38 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Chemours is estimated to report Q3 2026 earnings on Monday, November 2, 2026, after market closes. The conference call is scheduled for 8:00 AM ET.

Upcoming Earnings Announcement

Quarter
Q3 2026
Announcement Date
Time
After Market Closes
Conference Call
8:00 AM ET

What Analysts Expect from Chemours in Q3 2026

Chemours is expected to post earnings of $0.2662 per share on revenue of $1.53 billion. In the same quarter a year earlier Chemours reported $0.20 per share on revenue of $1.50 billion. Chemours last reported on August 4, 2026, posting $0.42 per share and missing the $0.4887 consensus estimate. Chemours has beaten the consensus EPS estimate in 5 of its last 8 quarters.

Consensus Estimates

Consensus EPS
$0.2662
Expected Revenue
$1.53 billion
Prior-Year EPS
$0.20
Prior-Year Revenue
$1.50 billion
Expected EPS Growth
+33.1%
Expected Revenue Growth
+2.5%

Recent Track Record

Last Reported
Q2 2026
Last Quarter EPS
$0.42 (Missed by -$0.0687)
Last Quarter Revenue
$1.59 billion
EPS Beat Rate
5 of last 8 quarters

Chemours Q3 2026 Earnings FAQ

Chemours (NYSE:CC) is estimated to report Q3 2026 earnings on Monday, November 2, 2026, after market closes. This date is estimated from past reporting schedules and may change once the company confirms it.

Chemours' Q3 2026 earnings conference call is scheduled for Monday, November 2, 2026 at 8:00 AM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date.

Analysts expect Chemours to post earnings of $0.2662 per share for Q3 2026.

The consensus revenue estimate for Chemours is $1.53 billion for Q3 2026.

Chemours Earnings Headlines

“The crisis that’s emerging now is just the tip of the iceberg,” says Dr. Martin D. Weiss, who has made shocking and accurate predictions for 55 years
Dr. Martin D. Weiss, who predicted the Dot-Com collapse and the failures of Fannie Mae, Bear Stearns, and Lehman Brothers, is warning of a developing financial crisis. The New York Times has credited him as among the first to see the dangers ahead, and Forbes dubbed him Mr. Independence. He says this emerging situation could trigger a chain reaction across banks and markets. Watch his free video breakdown and see the five steps he outlines for investors.tc pixel
See More Chemours Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Chemours? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Chemours and other key companies, straight to your email.

About Chemours

Chemours (NYSE:CC) (NYSE: CC) is a global chemistry company that develops and manufactures performance chemicals and advanced materials for industrial and consumer applications. The company serves customers in markets including automotive, construction, energy, electronics, healthcare, and general manufacturing.

Chemours operates through businesses focused on Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. Its products include titanium dioxide pigments used to provide whiteness and opacity in coatings, plastics, and paper; refrigerants and related thermal-management solutions; and high-performance fluoropolymers and specialty materials sold under brands such as Teflon™, Viton™, and Nafion™.

Headquartered in Wilmington, Delaware, Chemours serves customers globally through manufacturing facilities, research and development operations, and commercial activities across North America, Latin America, Europe, and Asia-Pacific. The company was formed in 2015 when it was separated from DuPont, becoming an independent publicly traded company.

View Chemours Profile